Ask AI

Reimagining Treatment Pathways in Schizophrenia: Challenging Old Models and Creating New Solutions

Emerging treatment approaches for schizophrenia are expanding beyond traditional dopamine-targeting antipsychotics. These downloadable slides from Psychopharmacology Update 2026 examine unmet treatment needs, muscarinic receptor pharmacology, and the clinical evidence for approved and investigational muscarinic agents. Explore differences in mechanisms of action, efficacy, tolerability, and practical considerations for integrating novel therapies into individualized schizophrenia management.

Schizophrenia Treatment Reimagined

Activity Information

Released: November 18, 2026